Advertisement
Advertisement
U.S. markets open in 6 hours 49 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Gritstone bio, Inc. (GRTS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.12+0.28 (+2.58%)
At close: 1:00PM EST
11.30 +0.18 (+1.62%)
After hours: 04:55PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close10.84
Open11.02
Bid0.00 x 1100
Ask0.00 x 3000
Day's Range10.62 - 11.50
52 Week Range2.86 - 35.20
Volume565,456
Avg. Volume1,036,388
Market Cap756.024M
Beta (5Y Monthly)0.06
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GRTS

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Gritstone bio, Inc.
    Analyst Report: Moderna, Inc.Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
All
News
Press Releases
Advertisement
Advertisement